Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies

Multilingual Wikipedia

In June 2020 the work Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies was on the 684,133rd place in the ranking of the most reliable and popular publications with DOI number in multilingual Wikipedia from readers' point of view (PR-score). If we consider only frequency of appearance of this source in references of Wikipedia articles (F-score), this work was on the 1,088,012th place in June 2020. From Wikipedians' point of view, "Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies" is the 1,094,165th most reliable publication with DOI number in different language versions of Wikipedia (AR-score).

PR-score:
684,133rd place
1,595
-557
AR-score:
1,094,165th place
47
0
F-score:
1,088,012th place
1
0

English Wikipedia (en)

PR-score:
578,880th place
1,595
-557
AR-score:
903,164th place
47
0
F-score:
945,025th place
1
0

BestRef shows popularity and reliability scores for sources in references of Wikipedia articles in different languages. Data extraction based on complex method using Wikimedia dumps. To find the most popular and reliable sources we used information about over 200 million references of Wikipedia articles. More details...